Document is current
Any future updates will be listed below
-
Authors
Maeda, Ryota https://orcid.org/0000-0002-1514-1071
Fujita, Junso https://orcid.org/0000-0003-1273-3917
Konishi, Yoshinobu https://orcid.org/0000-0003-1212-7212
Kazuma, Yasuhiro https://orcid.org/0000-0002-1046-8286
Yamazaki, Hiroyuki
Anzai, Itsuki
Watanabe, Tokiko
Yamaguchi, Keishi
Kasai, Kazuki https://orcid.org/0000-0002-1803-4036
Nagata, Kayoko
Yamaoka, Yutaro
Miyakawa, Kei
Ryo, Akihide
Shirakawa, Kotaro https://orcid.org/0000-0002-7469-1276
Sato, Kei https://orcid.org/0000-0003-4431-1380
Makino, Fumiaki https://orcid.org/0000-0001-9512-7087
Matsuura, Yoshiharu https://orcid.org/0000-0001-9091-8285
Inoue, Tsuyoshi
Imura, Akihiro https://orcid.org/0000-0002-8673-8983
Namba, Keiichi https://orcid.org/0000-0003-2911-5875
Takaori-Kondo, Akifumi https://orcid.org/0000-0001-7678-4284
- License Information
-
More Information
Article History
Received: 10 November 2021
Accepted: 24 June 2022
First Online: 6 July 2022
Competing interests
: Kyoto University, Osaka University, and COGNANO Inc. have filed a patent application (JP2021-170471) in connection with this research, on which R.M., J.F., A.T.-K., Ko.S., K.K., H.Y., A.I., F.M., Ke.N., K.Y., T.I., I.A., Y.M., Haruyasu Asahara and Maiko Moriguchi are inventors. A.I. is a stockholder of COGNANO Inc., which has patents and ownership of antibody sequences (JP2021-089414) and an in-house method of identifying antibodies (PCT/JP2019/021353) described in this study on which A.I. is an inventor. R.M., H.Y., and K.K. are employees of COGNANO Inc. The other authors declare no competing interests.
